Finnadvance is bridging the gap between in-vitro and in-vivo research with its microfluidic organ-on-chips for pharmaceutical drug research and development. With industry leading high throughput microphysiological culture platforms, complex in vivo biomechanical cues are mimicked on the in vitro cultures.

 

  • Founding year: 
  • 2019
  • Development phase:
  • Market-ready
  • Funding stage:
  • A round
  • Website: 
  • Contact person info: 
  • science(at)finnadvance.com
  • Team members: 
  • 18
  • Article:
  • Read an article about Finnadvance.